B'SYS GMBH Overview
Company Headquarters: Switzerland, Europe
Founded: 2004
Workforce: ~50
Company Working: B'SYS GMBH assists pharmaceutical companies with Ion Channel Discovery. The company's primary focus is on the rapid screening of new substances against ion channel drug targets. B'SYS' technological innovation addresses the need for electrophysiological tools in HTS Drug Discovery lead identification and candidate selection. Data generation takes place in a Good Laboratory Practice (GLP) environment. For the analysis of test items, cutting-edge technology is used by the company. Any test item's study results can be traced back to the original raw data, including the SOPs in effect at the time, the storage conditions of the test item, and the staff training records.
Strategy
B‘SYS GmbH focuses on delivering integrated solutions to the clients for drug discovery. The company also emphasizes on strategic collaborations to enhance its market presence in the industry. Also, the company strictly used state of the art equipment’s, qualified professionals to maintain speed, accuracy and efficiency during the process.
